AgingResearch.NewsJoin free

O-vanillin + RG-7112

O-vanillin + RG-7112 has been studied in 3 papers since 2023: none in people yet, 2 in animals, 1 in cells; 1 in the past year. The research so far is in animals and cells. The newest story, Oct 29, 2026: “Early drug dosing prevents pain-related behavior in mice”.

Intervention

3 papers study it3 more mention it11 findingsUpdated

PubChemPubChemChEBI

See all 6 papers on O-vanillin + RG-7112

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Cells and mice: a single group. Worms or flies and humans: nothing yet.

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Funders: Arthritis Society and 5 more
  • Animals2
  • Cells1

What did studies of O-vanillin + RG-7112 find?

9

Studies of O-vanillin + RG-7112 measured 9 outcomes; the most studied are inflammation (2 studies), cellular senescence (2) and spine degeneration (1).

Inflammation

downin human cells1downin mice1

2 studies

  1. O-vanillin + RG-7112 decreases inflammation in mice (sparc-/- mice).

    “alongside a dampening of pro-inflammatory senescence-associated secretory factors in these tissues”

    Animalssparc-/- miceintervertebral disc, vertebral endplate, vertebral bone, spinal cord

    Early drug dosing prevents pain-related behavior in mice

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)

  2. O-vanillin + RG-7112 decreases inflammation in cells from painful degenerate IVDs exposed to TLR-2/6 agonist.

    “proinflammatory cytokines, and neurotrophic factors.”

    Cellsin cells from painful degenerate IVDs exposed to TLR-2/6 agonist

    Senolytic Combination Treatment Is More Potent Than Single Drugs in Reducing Inflammatory and Senescence Burden in Cells from Painful Degenerating IVDs

    Biomolecules

More on Inflammation

Cellular senescence

downin human cells1downin mice1

2 studies

  1. O-vanillin + RG-7112 decreases cellular senescence in mice (sparc-/- mice).

    “Treatment reduced LBP and SASP factor release and removed SnCs from the IVD and spinal cord.”

    Animalssparc-/- miceintervertebral disc and spinal cord

    Senolytic treatment for low back pain

    Science advances

  2. O-vanillin + RG-7112 decreases cellular senescence in cells from painful degenerate IVDs exposed to TLR-2/6 agonist.

    “Compared to the single treatments, the combination of o-Vanillin and RG-7112 significantly reduced the amount of senescent IVD cells”

    Cellsin cells from painful degenerate IVDs exposed to TLR-2/6 agonist

    Senolytic Combination Treatment Is More Potent Than Single Drugs in Reducing Inflammatory and Senescence Burden in Cells from Painful Degenerating IVDs

    Biomolecules

More on Cellular senescence

Spine degeneration

downin mice1

1 study

  1. O-vanillin + RG-7112 protects against spine degeneration in mice (early intervention in sparc-/- mice).

    “Early senolytic intervention also preserved intervertebral disc volume and vertebral bone microarchitecture, indicating protection against structural spine degeneration.”

    Animalsearly intervention in sparc-/- miceintervertebral disc, vertebral bone

    Early drug dosing prevents pain-related behavior in mice

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)

More on Spine degeneration

Senescence markers

downin mice1

1 study

  1. O-vanillin + RG-7112 decreases senescence markers in mice (sparc-/- mice).

    “Treated mice exhibit a reduced expression of senescence markers in the intervertebral discs, vertebral endplates, vertebral bone, and spinal cord”

    Animalssparc-/- miceintervertebral disc, vertebral endplate, vertebral bone, spinal cord

    Early drug dosing prevents pain-related behavior in mice

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)

More on Senescence markers

Pain-related behavior

downin mice1

1 study

  1. O-vanillin + RG-7112 prevents pain-related behavior in mice (sparc-/- mice).

    “administration of the senolytic agents, o-vanillin and RG-7112, prevents the development of pain-related behavior in sparc-/- mice”

    Animalssparc-/- mice

    Early drug dosing prevents pain-related behavior in mice

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Bone quality

upin mice1

1 study

  1. O-vanillin + RG-7112 improves bone quality in mice (sparc-/- mice).

    “Treatment also lowered degeneration scores in the IVDs, improved vertebral bone quality, and reduced the expression of pain markers in the spinal cord.”

    Animalssparc-/- micevertebral bone

    Senolytic treatment for low back pain

    Science advances

Intervertebral disc degeneration

downin mice1

1 study

  1. O-vanillin + RG-7112 decreases intervertebral disc degeneration in mice (sparc-/- mice).

    “Treatment also lowered degeneration scores in the IVDs, improved vertebral bone quality, and reduced the expression of pain markers in the spinal cord.”

    Animalssparc-/- miceintervertebral disc

    Senolytic treatment for low back pain

    Science advances

Low back pain

downin mice1

1 study

  1. O-vanillin + RG-7112 decreases low back pain in mice (sparc-/- mice).

    “Treatment reduced LBP and SASP factor release and removed SnCs from the IVD and spinal cord.”

    Animalssparc-/- mice

    Senolytic treatment for low back pain

    Science advances

More on Low back pain

Neuronal sprouting

downin rat cells1

1 study

  1. O-vanillin + RG-7112 decreases neuronal sprouting in rat cells.

    “both single and combination treatments significantly reduced neuronal sprouting in rat adrenal pheochromocytoma (PC-12 cells).”

    Cellsrat adrenal pheochromocytoma (PC-12 cells)

    Senolytic Combination Treatment Is More Potent Than Single Drugs in Reducing Inflammatory and Senescence Burden in Cells from Painful Degenerating IVDs

    Biomolecules

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 1Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 0Nov 2026: 02 papers in 12 months
Advanced Science

Early drug dosing prevents pain-related behavior in mice

Weekly dosing for five months also preserved spinal disc volume and bone structure in mice prone to early spine degeneration.Weekly dosing for five months also preserved spinal disc volume and bone structure in mice prone to early spine degeneration.

Mouse studyInterventions
Paper

Related